Fibroblasts from patients with I-cell disease and pseudo-Hurler polydystrophy are deficient in uridine 5'-diphosphate-N-acetylglucosamine: glycoprotein N-acetylglucosaminylphosphotransferase activity.
Open accessThe DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
Newly synthesized acid hydrolases, destined for transport to lysosomes, acquire a phosphomannosyl targeting signal by the transfer of N-acetylglucosamine 1-phosphate from uridine 5'-diphosphate (UDP)-N-acetylglucosamine to a mannose residue of the acid hydrolase followed by removal of the outer, phosphodiester-linked N-acetylglucosamine to expose 6-phosphomannose. This study demonstrates that fibroblasts from patients with the lysosomal enzyme storage diseases, I-cell disease (mucolipidosis II) and pseudo-Hurler polydystrophy (mucolipidosis III), are severely deficient in UDP-N-acetylglucosamine:glycoprotein N-acetylglucosaminylphosphotransferase, the first enzyme of the sequence. The N-acetylglucosaminylphosphotransferase activity (assayed using endogenous acceptors) in cultures from six normal subjects ranged from 0.67 to 1.46 pmol N-acetylglucosamine-1-phosphate transferred/mg protein per h, whereas five pseudo-Hurler polydystrophy and five I-cell disease cultures transferred less than 0.02 pmol/mg protein per h. The activity in five other pseudo-Hurler cultures ranged from 0.02 to 0.27 pmol transferred/mg protein per h. The activity of alpha-N-acetylglucosaminyl phosphodiesterase, the enzyme responsible for phosphomonoester exposure, is normal or elevated in cultured fibroblasts from both I-cell disease and pseudo-Hurler polydystrophy patients. The deficiency of UDP-N-acetylglucosamine:glycoprotein N-acetylglucosaminylphosphotransferase explains the biochemical abnormalities previously observed in I-cell disease and pseudo-Hurler polydystrophy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 317,331
Kaplan, A., Achord, D. T., & Sly, W. S. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.5.2026 · Cited by 574
A hypothesis for I-cell disease: Defective hydrolases that do not enter lysosomes
Hickman, S., & Neufeld, E. F. (1972) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(72)90310-5 · Cited by 444
Biosynthesis of lysosomal enzymes in fibroblasts. Phosphorylation of mannose residues
Hasilik, A., & Neufeld, E. F. (1980) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)85586-2 · Cited by 400
Structural studies of phosphorylated high mannose-type oligosaccharides.
Varki, A., & Kornfeld, S. (1980) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)70385-8 · Cited by 236
Self-citationReitman, M. L., & Kornfeld, S. (1981) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)69430-5 · Cited by 229
Self-citationTabas, I., & Kornfeld, S. (1980) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)43616-2 · Cited by 223
Self-citationNatowicz, M. R., Chi, M. M., Lowry, O. H., & Sly, W. S. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.9.4322 · Cited by 213
The substrate specificities of endo-β-N-acetylglucosaminidases CII and H
Tai, T., Yamashita, K., & Kobata, A. (1977) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(77)91273-6 · Cited by 195
Varki, A., & Kornfeld, S. (1980) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)43507-7 · Cited by 174
Self-citation
Research works printed but not linked: 2
- J. B. Stanbury, J. B. Wyngaarden, and D. S. Fredrick- son, editors, McGraw-Hill Book Company, New York. 1299-1302.
- Reitman, M. L., and S. Komfeld. 1981. UDP-N-acetyl- glucosamine: glycoprotein N-acetylglucosamine-l-phos- photransferase-proposed enzyme for the phosphoryla- tion of the high mannose oligosaccharide units of lyso- somal enzymes. J. Biol. Chem. 256: in press.
Cited by
Varki, A. (2017) · Glycobiology · doi:10.1093/glycob/cww086 · Cited by 2,635
“All of this work culminated in the discovery of the biochemical defect in I-cell disease and related human genetic disorders, which turned out to be a failure of the initial phosphorylation mechanism (277, 280, 281).”
BackgroundSelf-citationLysosome biogenesis and lysosomal membrane proteins: trafficking meets function
Saftig, P., & Klumperman, J. (2009) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2745 · Cited by 1,648
“cgi?id=252500">I-cell disease (also known as mucolipidosis type II), lysosomal hydrolases do not acquire M6P tags because of a deficiency in N -acetylglucosamine (GlcNAc)-phosphotransferase activit”
BackgroundPathways of Protein Secretion in Eukaryotes
Kelly, R. B. (1985) · Science · doi:10.1126/science.2994224 · Cited by 1,052
Robinson, J. S., Klionsky, D. J., Banta, L. M., & Emr, S. D. (1988) · Molecular and Cellular Biology · doi:10.1128/mcb.8.11.4936 · Cited by 967
A Genetic Approach to Mammalian Glycan Function
Lowe, J. B., & Marth, J. D. (2003) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.72.121801.161809 · Cited by 594
Trafficking of lysosomal enzymes in normal and disease states.
Kornfeld, S. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112262 · Cited by 451
Self-citationRothman, J. H., & Stevens, T. H. (1986) · Cell · doi:10.1016/0092-8674(86)90819-6 · Cited by 423
Petersen, C. M., Nielsen, M. S., Nykjær, A., Jacobsen, L., Tommerup, N., Rasmussen, H. H., RØigaard, H., Gliemann, J., Madsen, P., & Moestrup, S. K. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.6.3599 · Cited by 399
Brefeldin A causes a microtubule-mediated fusion of the trans-Golgi network and early endosomes
Wood, S. A., Park, J. E., & Brown, W. J. (1991) · Cell · doi:10.1016/0092-8674(91)90533-5 · Cited by 384
Sly, W. S., & Fischer, H. D. (1982) · Journal of Cellular Biochemistry · doi:10.1002/jcb.1982.240180107 · Cited by 375
Powell, L. D., & Varki, A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.24.14243 · Cited by 312
Self-citationThe mannose-6-phosphate receptor for lysosomal enzymes is concentrated in cis Golgi cisternae
Brown, W. J., & Farquhar, M. G. (1984) · Cell · doi:10.1016/0092-8674(84)90223-x · Cited by 288
Mutations in the Lysosomal Enzyme–Targeting Pathway and Persistent Stuttering
Kang, C., Riazuddin, S., Mundorff, J., Krasnewich, D., Friedman, P., Mullikin, J. C., & Drayna, D. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0902630 · Cited by 261
Structure, biosynthesis and functions of glycoprotein glycans
Berger, E. G., Buddecke, E., Kamerling, J. P., Kobata, A., Paulson, J. C., & Vliegenthart, J. F. G. (1982) · Experientia · doi:10.1007/bf01959725 · Cited by 271
Varki, A., & Kornfeld, S. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)32790-x · Cited by 242
Self-citationThe lysosomal trafficking of sphingolipid activator proteins (SAPs) is mediated by sortilin
Lefrancois, S. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg629 · Cited by 218
[18] Lectin affinity chromatography of glycopeptides
Merkle, R. K., & Cummings, R. D. (1987) · Methods in Enzymology · doi:10.1016/0076-6879(87)38020-6 · Cited by 212
Dahms, N. (2002) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(02)00317-3 · Cited by 203
Molecular basis of variant pseudo-Hurler polydystrophy (mucolipidosis IIIC)
Raas-Rothschild, A., Cormier-Daire, V., Bao, M., Genin, E., Salomon, R., Brewer, K., Zeigler, M., Mandel, H., Toth, S., Roe, B., et al. (2000) · Journal of Clinical Investigation · doi:10.1172/jci5826 · Cited by 198
“Alternatively, GlcNAc-phosphotransferase can be directly assayed in cultured fibroblasts (11, 12).”
De Praeter, C. M., Gerwig, G. J., Bause, E., Nuytinck, L. K., Vliegenthart, J. F. G., Breuer, W., Kamerling, J. P., Espeel, M. F., Martin, J.-J. R., De Paepe, A. M., et al. (2000) · The American Journal of Human Genetics · doi:10.1086/302948 · Cited by 189
“…have been identified: (1) mucolipidosis II (I-cell disease) (MIM 252500) and mucolipidosis III (MIM 252600) (pseudo-Hurler polydystrophy) (Reitman et al. 1981); (2) leukocyte adhesion deficiency, type II (MIM 266265) (Etzioni et al. 1992); (3) congenital dyserythropoietic anemia type II…”
BackgroundGabel, C. A., Goldberg, D. E., & Kornfeld, S. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.3.775 · Cited by 186
Self-citationOwada, M., & Neufeld, E. F. (1982) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(82)91042-7 · Cited by 169
How can the products of a single gene be localized to more than one intracellular compartment?
Danpure, C. J. (1995) · Trends in Cell Biology · doi:10.1016/s0962-8924(00)89016-9 · Cited by 167
Kudo, M., Brem, M. S., & Canfield, W. M. (2006) · The American Journal of Human Genetics · doi:10.1086/500849 · Cited by 159
“GlcNAc-phosphotransferase activity is absent in MLII, reduced in MLIIIA, and altered in MLIIIC (Hasilik et al. 1981; Reitman et al. 1981; Varki et al. 1981, 1982; Waheed et al. 1982b).”
BackgroundPhenotype and genotype in mucolipidoses II and III alpha/beta: a study of 61 probands
Cathey, S. S., Leroy, J. G., Wood, T., Eaves, K., Simensen, R. J., Kudo, M., Stevenson, R. E., & Friez, M. J. (2010) · Journal of Medical Genetics · doi:10.1136/jmg.2009.067736 · Cited by 158
“-acetylglucosamine-1-phosphotransferase (EC 2.7.8.17), trivially termed UDP-GlcNAc-1-phosphotransferase (GlcNAc-1-PT or GNPT). The enzyme is composed of two α, two β and two γ polypeptides. It catalyses the first step in the biosynthesis of the mannose 6-phosphate (M6P) recognition marker in lysosomal hydrolases and o…”
BackgroundInfluentialMannose 6-phosphate-independent targeting of lysosomal enzymes in I-cell disease B lymphoblasts.
Glickman, J. N., & Kornfeld, S. (1993) · The Journal of cell biology · doi:10.1083/jcb.123.1.99 · Cited by 146
Self-citationWaheed, A., Pohlmann, R., Hasilík, A., FIGURA, K. V., Elsen, A. F. V., & Leroy, J. G. (1982) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(82)91076-2 · Cited by 160
Defective Sialic Acid Egress from Isolated Fibroblast Lysosomes of Patients with Salla Disease
Renlund, M., Tietze, F., & Gahl, W. A. (1986) · Science · doi:10.1126/science.3961501 · Cited by 147
Yamashita, K., Ideo, H., Ohkura, T., Fukushima, K., Yuasa, I., Ohno, K., & Takeshita, K. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53387-1 · Cited by 143
Sortilin mediates the lysosomal targeting of cathepsins D and H
Canuel, M., Korkidakis, A., Konnyu, K. J., & Morales, C. R. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.06.021 · Cited by 138
Imaging and imagination: understanding the endo-lysosomal system
Meel, E., & Klumperman, J. (2008) · Histochemistry and Cell Biology · doi:10.1007/s00418-008-0384-0 · Cited by 124
“In this disease, soluble lysosomal hydrolases do not acquire M6P groups due to a deWcient activity of the enzyme GlcNAc-phosphotransferase (Hasilik et al. 1981; Reitman et al. 1981).”
BackgroundDevelopmental abnormalities in transgenic mice expressing a sialic acid-specific 9-O-acetylesterase
Varki, A., Hooshmand, F., Diaz, S., Varki, N. M., & Hedrick, S. M. (1991) · Cell · doi:10.1016/0092-8674(91)90408-q · Cited by 134
Self-citationBovine UDP-N-acetylglucosamine:Lysosomal-enzyme N-Acetylglucosamine-1-phosphotransferase I
Bao, M., Booth, J. L., Elmendorf, B. J., & Canfield, W. M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.49.31437 · Cited by 134
A shortcut to the lysosome: The mannose-6-phosphate-independent pathway
Coutinho, M. F., Prata, M. J., & Alves, S. (2012) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2012.07.012 · Cited by 141
I-cell disease: A further report on its pathology
Martin, J., Leroy, J. G., van Eygen, M., & Ceuterick, C. (1984) · Acta Neuropathologica · doi:10.1007/bf00688114 · Cited by 132
Takasaki, S., Murray, G. J., Furbish, F. S., Brady, R. O., Barranger, J. A., & Kobata, A. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)90936-1 · Cited by 131
Hoflack, B., & Kornfeld, S. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.13.4428 · Cited by 123
Self-citationThe phosphorylation of beta-glucuronidase oligosaccharides in mouse P388D1 cells.
Goldberg, D. E., & Kornfeld, S. A. (1981) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)43006-2 · Cited by 122
Self-citationKudo, M., Bao, M., D'Souza, A., Ying, F., Pan, H., Roe, B. A., & Canfield, W. M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m509008200 · Cited by 115
Redistribution of mannose-6-phosphate receptors induced by tunicamycin and chloroquine.
Brown, W. J., Constantinescu, E., & Farquhar, M. G. (1984) · The Journal of cell biology · doi:10.1083/jcb.99.1.320 · Cited by 116
Maupin, K. A., Sinha, A., Eugster, E., Miller, J., Ross, J., Paulino, V., Keshamouni, V. G., Tran, N., Berens, M., Webb, C., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013002 · Cited by 113
“Glycan structures are involved in proper protein folding [19,20,21], intracellular trafficking [18,20,22], cell growth and differentiation, [20,23], adhesion and migration [18,24], and cell-based immunity [20,25], among other functions.”
BackgroundNielsen, R., Courtoy, P. J., Jacobsen, C., Dom, G., Lima, W. R., Jadot, M., Willnow, T. E., Devuyst, O., & Christensen, E. I. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700330104 · Cited by 110
Glycosylation diseases: Quo vadis?
Schachter, H., & Freeze, H. H. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.11.002 · Cited by 111
“Although patients with congenital abnormalities in glycan assembly (glycan biosynthesis and binding) are relatively rare, well over 40 human congenital diseases associated with glycogene mutations have been described to date: 16 Type I Congenital Disorders of Glycosylation (CDG-Ia to CDG-Ip) [7–14], 8 Type II CDGs (CD…”
BackgroundProia, R. L., & Neufeld, E. F. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.20.6360 · Cited by 134
Reuser, A. J. J., Kroos, M. A., Elferink, R. P. J. O., & Tager, J. M. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)39477-2 · Cited by 130
Dierks, T., Schlotawa, L., Frese, M., Radhakrishnan, K., FIGURA, K. V., & Schmidt, B. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2008.11.015 · Cited by 110
Jović, M., Kean, M. J., Szentpetery, Z., Polevoy, G., Gingras, A.-C., Brill, J. A., & Balla, T. (2012) · Molecular Biology of the Cell · doi:10.1091/mbc.e11-06-0553 · Cited by 104
“Taken together, these (IC 50 = 19 nM; Knight et al. , 2006; Balla et al. , 2008).”
Nauseef, W. (1986) · Blood · doi:10.1182/blood.v67.4.865.865 · Cited by 100
Intracellular protein trafficking defects in human disease
Amara, J. F., Cheng, S. H., & Smith, A. E. (1992) · Trends in Cell Biology · doi:10.1016/0962-8924(92)90101-r · Cited by 112
Reuser, A. J. J., Kroos, M. A., Willemsen, R., Swallow, D. M., Tager, J. M., & GALJAARD, H. (1987) · Journal of Clinical Investigation · doi:10.1172/jci113008 · Cited by 111
Natowicz, M. R., Baenziger, J., & Sly, W. S. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)34738-0 · Cited by 104
Golgi and Secreted Galactosyltransferas
Strous, G. J., & Schachter, H. (1986) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238609113610 · Cited by 103
Hasilík, A., & FIGURA, K. V. (1981) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1981.tb06440.x · Cited by 107
Genetics of Speech and Language Disorders
Kang, C. P., & Drayna, D. T. (2011) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-090810-183119 · Cited by 101
Biosynthesis and maturation of glucocerebrosidase in Gaucher fibroblasts
JONSSON, L. M. V., Murray, G. J., Sorrell, S. H., Strijland, A., Aerts, J. M. F. G., Ginns, E. I., Barranger, J. A., Tager, J. M., & Schram, A. W. (1987) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1987.tb11008.x · Cited by 94
Stoll, J., ROBBINS, A. R., & Krag, S. S. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.7.2296 · Cited by 99
Varki, A. P., Reitman, M. L., & Kornfeld, S. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.12.7773 · Cited by 89
Self-citationGal, S., Willingham, M. C., & Gottesman, M. M. (1985) · The Journal of Cell Biology · doi:10.1083/jcb.100.2.535 · Cited by 88
Waheed, A., Hasilík, A., & FIGURA, K. V. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)33717-7 · Cited by 99
Glycoproteins: their structure, biosynthesis and possible clinical implications
Schachter, H. (1984) · Clinical Biochemistry · doi:10.1016/s0009-9120(84)90360-6 · Cited by 101
Identification of novel lysosomal matrix proteins by proteome analysis
Kollmann, K., Mutenda, K. E., Balleininger, M., Eckermann, E., von Figura, K., Schmidt, B., & Lübke, T. (2005) · PROTEOMICS · doi:10.1002/pmic.200401247 · Cited by 85
Lysosomal Biogenesis in Lysosomal Storage Disorders
Karageorgos, L., Isaac, E. L., Brooks, D. A., Ravenscroft, E. M., Davey, R. C. A., Hopwood, J. J., & Meikle, P. J. (1997) · Experimental Cell Research · doi:10.1006/excr.1997.3581 · Cited by 83
Welsh, M. J., & Fick, R. B. (1987) · Journal of Clinical Investigation · doi:10.1172/jci113237 · Cited by 83
“I-cell disease is an example of a disease in which defective posttranslational modification of a glycoprotein increases extracellular levels of an otherwise intracellular protein (33).”
BackgroundWhen Mucolipidosis III meets Mucolipidosis II: GNPTA gene mutations in 24 patients
Bargal, R., Zeigler, M., Abu‐Libdeh, B., Zuri, V., Mandel, H., Neriah, Z. B., Stewart, F., Elcioglu, N. H., Hindi, T., Merrer, M. F. L., et al. (2006) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2006.03.003 · Cited by 78
Golgi Glycosylation and Human Inherited Diseases
Freeze, H. H., & Ng, B. G. (2011) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a005371 · Cited by 81
Wilson, P. D., Firestone, R. A., & Lenard, J. (1987) · The Journal of Cell Biology · doi:10.1083/jcb.104.5.1223 · Cited by 75
“Fibroblasts isolated from patients with I-cell disease and grown in continuous culture are deficient in one of the enzymes needed to attach M6P to lysosomal proteins (12, 25).”
Gabel, C. A., Dubey, L., Steinberg, S. P., Sherman, D. L., Gershon, M. D., & Gershon, A. A. (1989) · Journal of Virology · doi:10.1128/jvi.63.10.4264-4276.1989 · Cited by 74
“Lysosomal acid hydrolases are synthesized in the rough endoplasmic reticulum (ER) and are delivered to the lysosomal compartment by the attachment of a specific recognition marker, mannose 6-phosphate (Man 6-P), to the asparagine-linked oligosaccharides of the enzymes (24, 27, 35, 36, 40, 46).”
BackgroundCarpal tunnel syndrome in the mucopolysaccharidoses and related disorders.
Wraith, J. E., & Alani, S. M. (1990) · Archives of Disease in Childhood · doi:10.1136/adc.65.9.962 · Cited by 74
Brunetti, C. R., Burke, R. L., Hoflack, B., Ludwig, T. E., Dingwell, K. S., & Johnson, D. C. (1995) · Journal of Virology · doi:10.1128/jvi.69.6.3517-3528.1995 · Cited by 74
Mucolipidoses Overview: Past, Present, and Future
Khan, S. A., & Tomatsu, S. C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186812 · Cited by 74
“demonstrated that the fibroblasts from patients with I-cell disease and pseudo-Hurler polydystrophy were severely deficient in N-acetyl-glucosaminyl phosphotransferase activity, thus identifying the biochemical basis for these diseases [64].”
BackgroundMolecular order in mucolipidosis II and III nomenclature
Cathey, S. S., Kudo, M., Tiede, S., Raas‐Rothschild, A., Braulke, T., Beck, M., Taylor, H. A., Canfield, W. M., Leroy, J. G., Neufeld, E. F., et al. (2008) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.32193 · Cited by 77
“…OMIM # 252600) [Maroteaux and Lamy, 1966] are considered to be allelic disorders due to deficientUDP-N-acetylglucosamine: lysosomal hydrolase N-acetyl-1-phosphotransferase (IUBMB # 2.7.8.17) [Hasilik et al., 1981; Reitman et al., 1981], commonly termed UDP-GlcNAc 1-phosphotransferase (GlcNAcPT).”
BackgroundInfluentialVelho, R. V., Harms, F. L., Danyukova, T., Ludwig, N. F., Friez, M. J., Cathey, S. S., Filocamo, M., Tappino, B., Güneş, N., Tüysüz, B., et al. (2019) · Human Mutation · doi:10.1002/humu.23748 · Cited by 83
The biogenesis of the MHC class II compartment in human I-cell disease B lymphoblasts.
Glickman, J. N., Morton, P. A., Slot, J. W., Kornfeld, S., & Geuze, H. J. (1996) · The Journal of cell biology · doi:10.1083/jcb.132.5.769 · Cited by 70
Self-citationCongenital dyserythropoietic anemia type II: molecular basis and clinical aspects.
Iolascon, A., D’Agostaro, G., Perrotta, S., Izzo, P., Tavano, R., & del Giudice, B. M. (1996) · PubMed · Cited by 69
Mannose 6-phosphate receptors and their role in targeting proteins to lysosomes
Pfeffer, S. R. (1988) · The Journal of Membrane Biology · doi:10.1007/bf01871928 · Cited by 69
Schuchman, E. H., & Wasserstein, M. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-35762-3.00053-6 · Cited by 67
Brown, W. J., & Farquhar, M. G. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.16.5135 · Cited by 71
Lazzarino, D. A., & Gabel, C. A. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)81485-0 · Cited by 63
D’Agostaro, G., Zingoni, A., Schachter, H., Bendiak, B. K., Moritz, R. L., & Simpson, R. J. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.25.15211 · Cited by 61
Nishimura, Y., Rosenfeld, M. G., Kreibich, G., Gubler, U., Sabatini, D. D., Adesnik, M., & Andy, R. J. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.19.7292 · Cited by 70
Biosynthesis and maturation of arylsulfatase B in normal and mutant cultured human fibroblasts.
STECKEL, F., Hasilík, A., & FIGURA, K. V. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)43862-2 · Cited by 64
Tiede, S., Muschol, N., Reutter, G., Cantz, M., Ullrich, K., & Braulke, T. (2005) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.30868 · Cited by 60
“In these patients, phosphotransferase activity is reduced and soluble lysosomal enzymes are excreted mainly in the body fluids and serum [Reitman et al., 1981].”
BackgroundSharma, J., di Ronza, A., Lotfi, P., & Sardiello, M. (2018) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-080317-061804 · Cited by 55
I‐cell disease: clinical studies of 21 Japanese cases
Okada, S., Ōwada, M., Sakiyama, T., Yutaka, T., & Ogawa, M. (1985) · Clinical Genetics · doi:10.1111/j.1399-0004.1985.tb00388.x · Cited by 63
The osteodystrophy of mucolipidosis type III and the effects of intravenous pamidronate treatment
Robinson, C., Baker, N., Noble, J., King, A., Dávid, G., Sillence, D. O., Hofman, P. L., & Cundy, T. (2003) · Journal of Inherited Metabolic Disease · doi:10.1023/a:1022935115323 · Cited by 55
“The plasma activities of these enzymes may thus be high, but they are ineffective (Kornfeld and Sly 2001; Reitman et al 1981 ).”
BackgroundZeng, J., Racicott, J., & Morales, C. R. (2009) · Experimental Cell Research · doi:10.1016/j.yexcr.2009.08.016 · Cited by 54
The carbohydrate deficient glycoprotein syndrome in three Japanese children
Ohno, K., Yuasa, I., Akaboshi, S., Itoh, M., Yoshida, K., Ehara, H., Ochiai, Y., & Takeshita, K. (1992) · Brain and Development · doi:10.1016/s0387-7604(12)80276-2 · Cited by 54
Ikeda, K., Hirayama, M., Hirota, Y., Asa, E., Seki, J., & Tanaka, Y. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.09.121 · Cited by 54
Gabius, H., Čudić, M., Diercks, T., Kaltner, H., Kopitz, J., Mayo, K. H., Murphy, P. V., Oscarson, S., Roy, R., Schedlbauer, A., et al. (2021) · ChemBioChem · doi:10.1002/cbic.202100327 · Cited by 55
Byrd, J. C., & MacDonald, R. G. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000010200 · Cited by 52
Clinical Aspects of Glycoprotein Biosynthesis
Brockhausen, I., & Paulson, J. C. (1993) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408369309084666 · Cited by 55
Activation of Coagulation Factor V by a Platelet Protease
Kane, W. H., Mruk, J. S., & Majerus, P. W. (1982) · Journal of Clinical Investigation · doi:10.1172/jci110697 · Cited by 50
“(26), 13-glucuronidase according to Meisler et al.”
Ramsay, S. L., Meikle, P. J., Hopwood, J. J., & Clements, P. R. (2005) · Analytical Biochemistry · doi:10.1016/j.ab.2005.06.042 · Cited by 49
Properties of N-acetyl-beta-D-hexosaminidase from isolated normal and I-cell lysosomes.
Miller, A. L., Kress, B. C., Stein, R., Kinnon, C., Kern, H., Schneider, J. A., & Harms, E. (1981) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52555-8 · Cited by 53
Animal models for mucopolysaccharidoses and their clinical relevance
Haskins, M. E., Casal, M. L., Ellinwood, N. M., Melniczek, J. R., Mazrier, H., & Giger, U. (2002) · Acta Paediatrica · doi:10.1080/080352502762458003 · Cited by 48
Plante, M.-M., Claveau, S., Lepage, P., Lavoie, È., Brunet, S., Roquis, D., Morin, C., Vézina, H., & Laprise, C. (2008) · Clinical Genetics · doi:10.1111/j.1399-0004.2007.00954.x · Cited by 47
Mucolipidosis III is genetically heterogeneous.
Honey, N. K., Mueller, O. T., Little, L. E., Miller, A. L., & Shows, T. B. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.23.7420 · Cited by 50
Mueller, O. T., Honey, N. K., Little, L. E., Miller, A. L., & Shows, T. B. (1983) · Journal of Clinical Investigation · doi:10.1172/jci111025 · Cited by 48
“The primary defect in both ML II and ML III was shown to be a deficiency of uridine diphosphate N-acetyl glucosamine: lysosomal enzyme precursor Nacetyl-glucosamine-1-phosphate transferase (GlcNAcP transferase) activity, which synthesizes the marker (13-17).”
BackgroundDefining the Pathway for Tat-mediated Delivery of β-Glucuronidase in Cultured Cells and MPS VII Mice
Orii, K. O., Grubb, J. H., Vogler, C., Levy, B., Tan, Y., Markova, K., Davidson, B. L., Mao, Q., Orii, T., Kondo, N., et al. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2005.02.031 · Cited by 44
“Decreased phosphorylation could result from the effect of the increased positive charge or subtle changes in the three-dimensional structure of GUS, which make it less effective as a substrate for the phosphotransferase, which normally recognizes three-dimensional patches on acid hydrolases [23].”
BackgroundNishimura, F., Naruishi, H., Naruishi, K., Yamada, T., Sasaki, J., Peters, C., Uchiyama, Y., & Murayama, Y. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64483-5 · Cited by 51
“I-cell disease (mucolipidosis II) is a rare congenital lysosomal storage disease characterized by a defect in N-acetylglucosamone-1-phosphotransferase (UDP-Nacetyl-glucosamine), which is involved in the processing and maturation of various lysosomal enzymes.(11,12) As a result, the activity of almost all lysosomal enz…”
Background
Metadata
- Authors
- Reitman, M. L., Varki, A., & Kornfeld, S.
- Affiliations
- Washington University in St. Louis (US)
- Venue
- Journal of Clinical Investigation
- Published
- 1981-05-01
- Volume
- 67
- Issue
- 5
- Pages
- 1574-1579
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC370727
- OpenAlex
- W2118487772
- Cited by
- 321
- References
- 16
- Citations by year
- 2025: 2 · 2024: 4 · 2023: 1 · 2022: 3 · 2021: 3 · 2020: 5 · 2019: 4 · 2018: 5 · 2017: 3 · 2016: 4 · 2015: 1 · 2014: 1 · 2013: 2 · 2012: 7
- FWCI
- 35.25
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (CA08759)
- National Heart, Lung, and Blood Institute (T32HL007088)
- National Cancer Institute (R01CA008759)
- National Institute of General Medical Sciences (GM07200, T32GM007200)
- Topics
- Health Sciences › Medicine › Genetics (clinical) › Lysosomal Storage Disorders Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Glycogen Storage Diseases and Myoclonus
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glycosylation and Glycoproteins Research
- Keywords
- I-cell disease, mucolipidosis II, mucolipidosis III, UDP-N-acetylglucosamine, lysosomal enzyme targeting, fibroblasts, lysosomal storage disease
- MeSH terms
- beta-Galactosidase, Cells, Cultured, Fibroblasts, Humans, Mucopolysaccharidosis I, Mucolipidoses, Phosphoric Diester Hydrolases, Phosphotransferases, Mucopolysaccharidosis II, Transferases (Other Substituted Phosphate Groups)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.